NexgenRx Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for NexgenRx.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Insurance earnings growth | 5.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Optimistic Investors Push NexgenRx Inc. (CVE:NXG) Shares Up 45% But Growth Is Lacking
May 21We Discuss Why NexgenRx Inc.'s (CVE:NXG) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 10NexgenRx Inc.'s (CVE:NXG) Price Is Out Of Tune With Revenues
Mar 14Here's Why We Think NexgenRx (CVE:NXG) Might Deserve Your Attention Today
Mar 07Is Now The Time To Put NexgenRx (CVE:NXG) On Your Watchlist?
Oct 18Does NexgenRx (CVE:NXG) Deserve A Spot On Your Watchlist?
Nov 30What NexgenRx Inc.'s (CVE:NXG) 32% Share Price Gain Is Not Telling You
Aug 24Here's Why NexgenRx Inc.'s (CVE:NXG) CEO May Have Their Pay Bumped Up
Jun 03NexgenRx Inc.'s (CVE:NXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 19How Much Is NexgenRx's (CVE:NXG) CEO Getting Paid?
Dec 28In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as NexgenRx has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 15 | 0 | 2 | 2 | N/A |
3/31/2024 | 15 | 0 | 1 | 1 | N/A |
12/31/2023 | 14 | 0 | 1 | 1 | N/A |
9/30/2023 | 14 | 0 | 0 | 0 | N/A |
6/30/2023 | 13 | 0 | 0 | 1 | N/A |
3/31/2023 | 13 | 0 | 1 | 1 | N/A |
12/31/2022 | 13 | 0 | 1 | 1 | N/A |
9/30/2022 | 13 | 3 | 3 | 4 | N/A |
6/30/2022 | 13 | 4 | 2 | 3 | N/A |
3/31/2022 | 12 | 4 | 2 | 3 | N/A |
12/31/2021 | 12 | 4 | 2 | 4 | N/A |
9/30/2021 | 11 | 2 | 1 | 2 | N/A |
6/30/2021 | 11 | 2 | 1 | 3 | N/A |
3/31/2021 | 11 | 2 | 1 | 3 | N/A |
12/31/2020 | 11 | 2 | 2 | 3 | N/A |
9/30/2020 | 10 | 1 | 1 | 2 | N/A |
6/30/2020 | 10 | 0 | 1 | 2 | N/A |
3/31/2020 | 10 | 0 | 1 | 1 | N/A |
12/31/2019 | 10 | 0 | 0 | 1 | N/A |
9/30/2019 | 9 | 0 | 0 | 1 | N/A |
6/30/2019 | 9 | 0 | 0 | 0 | N/A |
3/31/2019 | 8 | 0 | 0 | 0 | N/A |
12/31/2018 | 7 | -1 | -1 | -1 | N/A |
9/30/2018 | 6 | -1 | -1 | -1 | N/A |
6/30/2018 | 6 | -1 | -1 | -1 | N/A |
3/31/2018 | 6 | -1 | N/A | -1 | N/A |
12/31/2017 | 6 | -1 | N/A | 0 | N/A |
9/30/2017 | 6 | 0 | N/A | 0 | N/A |
6/30/2017 | 6 | 0 | N/A | 0 | N/A |
3/31/2017 | 6 | 1 | N/A | 0 | N/A |
12/31/2016 | 6 | 1 | N/A | 0 | N/A |
9/30/2016 | 5 | 0 | N/A | 0 | N/A |
6/30/2016 | 5 | 0 | N/A | 0 | N/A |
3/31/2016 | 5 | 0 | N/A | 0 | N/A |
12/31/2015 | 5 | 0 | N/A | 0 | N/A |
9/30/2015 | 5 | 0 | N/A | 0 | N/A |
6/30/2015 | 4 | 0 | N/A | 0 | N/A |
3/31/2015 | 4 | 0 | N/A | 0 | N/A |
12/31/2014 | 4 | 0 | N/A | -1 | N/A |
9/30/2014 | 4 | 0 | N/A | 0 | N/A |
6/30/2014 | 4 | 0 | N/A | 0 | N/A |
3/31/2014 | 5 | 0 | N/A | 0 | N/A |
12/31/2013 | 5 | 1 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NXG's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if NXG's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if NXG's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if NXG's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if NXG's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NXG's Return on Equity is forecast to be high in 3 years time